DMA-5-hemiFLY:
495,
496,
497,
503 · SF:
670,
671 ·
851,
852,
860
Blaazer, AR; Smid, P; Kruse, CG. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors. ChemMedChem, 15 Sep 2008, 3 (9), 1299–1309. 461 kB. https://doi.org/10.1002/cmdc.200800133 #35
Nichols, DE; Snyder, SE; Oberlender, R; Johnson, MP; Huang, X. 2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines. J. Med. Chem., 1 Jan 1991, 34 (1), 276–281. 833 kB. https://doi.org/10.1021/jm00105a043
Nichols, DE. Medicinal chemistry and structure-activity relationships. In Amphetamine and its Analogs; Cho, AK; Segal, DS, Eds., Academic Press, San Diego, CA, 1 Jan 1994; pp 3–41. 8.1 MB. #34
Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure. SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. #246 In German. MS,NMR,IR
N,N-Dimethyl-MDA · MDDM · MDDMA
N-Ethyl-MDA · EA-1304 · EVE · MDE · MDEA · PAL-192
4-Methoxybuphedrone · MeO-B
α-Et-MDA · α-Et-α-Me-MDPEA
N-Methylheliamine · DMHM-4
4-Methoxy-N,N-dimethylcathinone · Dimethedrone
4-Methoxyethcathinone · Ethedrone